Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.57 $71,022 - $96,386
-169,100 Reduced 30.89%
378,400 $181,000
Q3 2023

Nov 14, 2023

BUY
$0.44 - $0.98 $48,048 - $107,016
109,200 Added 24.91%
547,500 $317,000
Q2 2023

Aug 14, 2023

BUY
$0.5 - $0.67 $24,150 - $32,361
48,300 Added 12.38%
438,300 $232,000
Q1 2023

May 15, 2023

SELL
$0.66 - $1.13 $343,992 - $588,956
-521,200 Reduced 57.2%
390,000 $273,000
Q4 2022

Feb 14, 2023

SELL
$0.85 - $1.54 $478,635 - $867,174
-563,100 Reduced 38.19%
911,200 $838,000
Q3 2022

Nov 14, 2022

SELL
$1.16 - $1.89 $207,872 - $338,688
-179,200 Reduced 10.84%
1,474,300 $1.8 Million

Others Institutions Holding ACB

About AURORA CANNABIS INC


  • Ticker ACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 300,436,992
  • Market Cap $1.34B
  • Description
  • Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried ...
More about ACB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.